Are you Dr. Nada?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 37 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1901 W Harrison St
Chicago, IL 60612Phone+1 312-864-6500
Summary
- Dr. Adel Nada, MD is an internist in Chicago, Illinois. He is currently licensed to practice medicine in Illinois.
Education & Training
Cook County Health and Hospitals SystemResidency, Internal Medicine, 1997 - 2000
University of Alexandria Faculty of MedicineClass of 1994
Certifications & Licensure
IL State Medical License 1999 - 2026
Publications & Presentations
PubMed
- 4 citationsHarnessing regulatory T cells to establish immune tolerance.Patrick Ho, Ellen Cahir-McFarland, Jason D Fontenot, Tracey Lodie, Adel Nada
Science Translational Medicine. 2024-03-13 - 98 citationsThe RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina.Thomas J. Povsic, Timothy D. Henry, Jay H. Traverse, F. David Fortuin, Gary L. Schaer
JACC. Cardiovascular Interventions. 2016-08-08 - 15 citationsStudying navitoclax, a targeted anticancer drug, in healthy volunteers--ethical considerations and risk/benefit assessments and management.Hao Xiong, Rajendra Pradhan, Adel Nada, Andrew Krivoshik, Kyle D. Holen
Anticancer Research. 2014-07-01
Press Mentions
GentiBio Nets $157 Million to Restore Immune Tolerance with TregsAugust 11th, 2021- GentiBio Launches with $20M Seed Funding to Develop Engineered Regulatory T Cells for Autoimmune and Inflammatory DiseasesAugust 7th, 2020
- Start-up to Engineer T-cells for Autoimmune DiseasesAugust 6th, 2020
- Join now to see all
